• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由死亡信号引发的线粒体决定细胞对抗凋亡BCL-2家族成员的依赖性。

Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members.

作者信息

Certo Michael, Del Gaizo Moore Victoria, Nishino Mari, Wei Guo, Korsmeyer Stanley, Armstrong Scott A, Letai Anthony

机构信息

Department of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts 02115, USA.

出版信息

Cancer Cell. 2006 May;9(5):351-65. doi: 10.1016/j.ccr.2006.03.027.

DOI:10.1016/j.ccr.2006.03.027
PMID:16697956
Abstract

We show that the antiapoptotic proteins BCL-2, BCL-XL, MCL-1, BFL-1, and BCL-w each bear a unique pattern of interaction with a panel of peptides derived from BH3 domains of BH3-only proteins. Cellular dependence on an antiapoptotic protein for survival can be decoded based on the pattern of mitochondrial sensitivity to this peptide panel, a strategy that we call BH3 profiling. Dependence on antiapoptotic proteins correlates with sequestration of activator BH3-only proteins like BID or BIM by antiapoptotic proteins. Sensitivity to the cell-permeable BCL-2 antagonist ABT-737 is also related to priming of BCL-2 by activator BH3-only molecules. Our data allow us to distinguish a cellular state we call "primed for death," which can be determined by BH3 profiling and which correlates with dependence on antiapoptotic family members for survival.

摘要

我们发现抗凋亡蛋白BCL-2、BCL-XL、MCL-1、BFL-1和BCL-w各自与一组源自仅含BH3结构域蛋白的BH3结构域的肽段呈现独特的相互作用模式。细胞对某种抗凋亡蛋白的生存依赖性可根据线粒体对该肽段组的敏感性模式来解读,我们将此策略称为BH3分析。对抗凋亡蛋白的依赖性与抗凋亡蛋白对激活剂类仅含BH3结构域蛋白(如BID或BIM)的隔离有关。对细胞可渗透的BCL-2拮抗剂ABT-737的敏感性也与激活剂类仅含BH3结构域分子对BCL-2的启动作用有关。我们的数据使我们能够区分一种我们称为“死亡致敏”的细胞状态,这种状态可通过BH3分析来确定,并且与生存对抗凋亡家族成员的依赖性相关。

相似文献

1
Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members.由死亡信号引发的线粒体决定细胞对抗凋亡BCL-2家族成员的依赖性。
Cancer Cell. 2006 May;9(5):351-65. doi: 10.1016/j.ccr.2006.03.027.
2
Differences in the mechanisms of proapoptotic BH3 proteins binding to Bcl-XL and Bcl-2 quantified in live MCF-7 cells.在活 MCF-7 细胞中定量测定促凋亡 BH3 蛋白与 Bcl-XL 和 Bcl-2 结合的机制差异。
Mol Cell. 2012 Mar 30;45(6):754-63. doi: 10.1016/j.molcel.2012.01.030.
3
BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly.仅含BH3结构域的蛋白质的BH3结构域通过直接和间接方式对Bax介导的线粒体膜通透性进行差异调节。
Mol Cell. 2005 Feb 18;17(4):525-35. doi: 10.1016/j.molcel.2005.02.003.
4
B cell lymphoma-2 (BCL-2) homology domain 3 (BH3) mimetics demonstrate differential activities dependent upon the functional repertoire of pro- and anti-apoptotic BCL-2 family proteins.B细胞淋巴瘤-2(BCL-2)同源结构域3(BH3)模拟物表现出依赖于促凋亡和抗凋亡BCL-2家族蛋白功能谱的不同活性。
J Biol Chem. 2014 Sep 19;289(38):26481-26491. doi: 10.1074/jbc.M114.569632. Epub 2014 Aug 5.
5
Interactions of pro-apoptotic BH3 proteins with anti-apoptotic Bcl-2 family proteins measured in live MCF-7 cells using FLIM FRET.利用 FLIM-FRET 在活 MCF-7 细胞中测量促凋亡 BH3 蛋白与抗凋亡 Bcl-2 家族蛋白的相互作用。
Cell Cycle. 2012 Oct 1;11(19):3536-42. doi: 10.4161/cc.21462. Epub 2012 Aug 16.
6
Targeting ERK1/2-bim signaling cascades by BH3-mimetic ABT-737 as an alternative therapeutic strategy for oral cancer.靶向ERK1/2-bim信号级联反应的BH3模拟物ABT-737作为口腔癌的替代治疗策略
Oncotarget. 2015 Nov 3;6(34):35667-83. doi: 10.18632/oncotarget.5523.
7
BCL-2 dependence and ABT-737 sensitivity in acute lymphoblastic leukemia.急性淋巴细胞白血病中的BCL-2依赖性和ABT-737敏感性
Blood. 2008 Feb 15;111(4):2300-9. doi: 10.1182/blood-2007-06-098012. Epub 2007 Dec 4.
8
BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents.BH3分析可识别出三类不同的凋亡阻滞情况,以预测对ABT-737和传统化疗药物的反应。
Cancer Cell. 2007 Aug;12(2):171-85. doi: 10.1016/j.ccr.2007.07.001.
9
Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1.淋巴瘤细胞中上调 MCL-1 和 BFL-1 导致对 ABT-737 产生获得性耐药。
Blood. 2010 Apr 22;115(16):3304-13. doi: 10.1182/blood-2009-07-233304. Epub 2010 Mar 2.
10
Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737.慢性淋巴细胞白血病需要BCL2来隔离促死亡蛋白BIM,这解释了其对BCL2拮抗剂ABT - 737的敏感性。
J Clin Invest. 2007 Jan;117(1):112-21. doi: 10.1172/JCI28281.

引用本文的文献

1
Molecular mechanisms underlying HRK interaction with BCL-XL and BCL-2 reveal specificity determinants for BH3 mimetics.HRK与BCL-XL和BCL-2相互作用的分子机制揭示了BH3模拟物的特异性决定因素。
iScience. 2025 Aug 6;28(9):113309. doi: 10.1016/j.isci.2025.113309. eCollection 2025 Sep 19.
2
Exploration of Multiconformers to Extract Information About Structural Deformation Undergone by a Protein Target: Illustration on the Bcl-xL Target.探索多构象体以提取蛋白质靶点经历的结构变形信息:以Bcl-xL靶点为例
Molecules. 2025 Aug 12;30(16):3355. doi: 10.3390/molecules30163355.
3
Systems biology-enabled targeting of NF-κΒ and BCL2 overcomes microenvironment-mediated BH3-mimetic resistance in DLBCL.
基于系统生物学的NF-κΒ和BCL2靶向作用克服了弥漫性大B细胞淋巴瘤中微环境介导的BH3模拟物耐药性。
Cell Death Dis. 2025 Aug 16;16(1):620. doi: 10.1038/s41419-025-07942-0.
4
BCL-xL dependency in chromophobe renal cell carcinoma.肾嫌色细胞癌中BCL-xL的依赖性
Cancer Gene Ther. 2025 Aug 16. doi: 10.1038/s41417-025-00953-1.
5
mTOR inhibition sensitizes T-ALL cells to Venetoclax through engagement of the integrated stress response.mTOR抑制通过整合应激反应使T-ALL细胞对维奈托克敏感。
Signal Transduct Target Ther. 2025 Aug 4;10(1):246. doi: 10.1038/s41392-025-02368-8.
6
Lung cancer-associated fibroblasts-mediated collagen deposition drives mediastinal lymph node metastasis in non-small cell lung cancer.肺癌相关成纤维细胞介导的胶原沉积驱动非小细胞肺癌纵隔淋巴结转移。
Front Oncol. 2025 Jun 12;15:1597585. doi: 10.3389/fonc.2025.1597585. eCollection 2025.
7
Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.开发一种新型生物标志物平台,用于分析关键蛋白质-蛋白质相互作用以预测BH3模拟药物的疗效。
Cancers (Basel). 2025 May 31;17(11):1852. doi: 10.3390/cancers17111852.
8
Grafted Coiled-Coil Peptides as Multivalent Scaffolds for Protein Recognition.作为用于蛋白质识别的多价支架的嫁接卷曲螺旋肽
ACS Chem Biol. 2025 Jun 20;20(6):1309-1318. doi: 10.1021/acschembio.5c00137. Epub 2025 Jun 5.
9
Development of a robust BH3 drug toolkit for precision medicine in hematologic malignancies.开发用于血液系统恶性肿瘤精准医学的强大BH3药物工具包。
Theranostics. 2025 Apr 21;15(12):5705-5718. doi: 10.7150/thno.107852. eCollection 2025.
10
Re-appraising assays on permeabilized blood cancer cells testing venetoclax or other BH3 mimetic agents selectively targeting pro-survival BCL2 proteins.重新评估针对透化处理的血癌细胞进行的检测,这些检测用于测试维奈托克或其他选择性靶向促生存BCL2蛋白的BH3模拟剂。
Cell Death Differ. 2025 Apr 9. doi: 10.1038/s41418-025-01487-7.